We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.96%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$15.8B
AUM Growth
+$600M
(+4%)
Cap. Flow
+$62.2M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
39.24%
Holding
1,522
New
71
Increased
243
Reduced
326
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$93.8M |
| 2 |
Zimmer Biomet
ZBH
|
+$62.6M |
| 3 |
Gilead Sciences
GILD
|
+$35.1M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$25.2M |
| 5 |
Honeywell
HON
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$90.2M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$33.6M |
| 3 |
AstraZeneca
AZN
|
+$23.3M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$20.1M |
| 5 |
Innoviva
INVA
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.27% |
| 2 | Healthcare | 11.8% |
| 3 | Industrials | 8.53% |
| 4 | Technology | 7.67% |
| 5 | Energy | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Innoviva
INVA
$1.58B
| $13.4M | 0.08% |
448,887
-829,314
| -65% | -$19.9M |
|
|
WBA
152
DELISTED
Walgreens Boots Alliance
WBA
| $13.3M | 0.08% |
179,416
+106
| +0.1% | +$7.41K |
|
153
Saic
SAIC
$5.12B
| $13.2M | 0.08% |
299,624
-1,597
| -0.5% | -$63.1K |
|
|
SE
154
DELISTED
Spectra Energy Corp Wi
SE
| $13M | 0.08% |
305,183
-16,900
| -5% | -$677K |
|
|
CELG
155
DELISTED
Celgene Corp
CELG
| $12.9M | 0.08% |
150,650
-204
| -0.1% | -$15.5K |
|
156
McCormick & Company Non-Voting
MKC
$13.7B
| $11.7M | 0.07% |
327,456
-400
| -0.1% | -$14.3K |
|
157
Commercial Vehicle Group
CVGI
$159M
| $11.7M | 0.07% |
1,161,040
| – | – |
|
|
PMBC
158
DELISTED
Pacific Mercantile Bancorp
PMBC
| $11.6M | 0.07% |
1,735,919
-6,184
| -0.4% | -$40.4K |
|
159
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $11.5M | 0.07% |
59,002
-5,243
| -8% | -$997K |
|
160
Capital One
COF
$125B
| $11.3M | 0.07% |
137,377
-471
| -0.3% | -$36.6K |
|
161
Brookfield Renewable
BEP
$10B
| $11.2M | 0.07% |
712,085
-4,597
| -0.6% | -$71.5K |
|
162
Enterprise Products Partners
EPD
$84.2B
| $11.2M | 0.07% |
285,500
-2,500
| -0.9% | -$92.2K |
|
163
Navient
NAVI
$811M
| $11.1M | 0.07% |
+627,603
| New | +$10.4M |
|
|
GAS
164
DELISTED
AGL Resources Inc
GAS
| $11.1M | 0.07% |
201,584
-1,350
| -0.7% | -$71K |
|
|
MHFI
165
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $10.9M | 0.07% |
131,653
-4,484
| -3% | -$353K |
|
166
Yum! Brands
YUM
$41.1B
| $10.9M | 0.07% |
186,411
| – | – |
|
167
Devon Energy
DVN
$52.3B
| $10.8M | 0.07% |
135,576
+400
| +0.3% | +$29.1K |
|
168
Agilent Technologies
A
$39.2B
| $10.5M | 0.07% |
254,668
+12,512
| +5% | +$502K |
|
|
XUE
169
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
| $10.4M | 0.07% |
2,347,592
+316,449
| +16% | +$1.58M |
|
170
Buckle
BKE
$2.19B
| $10.2M | 0.06% |
230,753
-400
| -0.2% | -$18.3K |
|
171
Merck
MRK
$323B
| $10.2M | 0.06% |
185,181
-12,219
| -6% | -$667K |
|
172
Chevron
CVX
$390B
| $10.2M | 0.06% |
78,240
-5,075
| -6% | -$631K |
|
|
TWC
173
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $10.2M | 0.06% |
69,272
+10,691
| +18% | +$1.5M |
|
174
Essential Utilities
WTRG
$11.2B
| $10.1M | 0.06% |
386,520
+4,706
| +1% | +$118K |
|
175
Theravance Biopharma
TBPH
$875M
| $9.59M | 0.06% |
+300,732
| New | +$9.05M |
|
Similar funds
SAM
First Manhattan's Q2 2014 Portfolio in Review
As of Q2 2014, First Manhattan held 1,522 positions worth $15.8B, up 4% from $15.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
First Manhattan's Q2 2014 filing shows 71 new, 243 increased, 326 reduced and 55 closed positions. Its largest new stake was Navient: 627,603 shares worth $11.1M. The largest sale was Gen Digital, an estimated $90.2M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q2 2014 buy was Navient: 627,603 shares worth $11.1M.
- First Manhattan added most to Oracle in Q2 2014, an estimated $93.8M increase.
- First Manhattan's biggest Q2 2014 reduction was Gen Digital, cutting an estimated $90.2M.
- First Manhattan fully exited Cardiovascular Systems, Inc. in Q2 2014, selling an estimated $8.27M.
- First Manhattan's ten largest holdings make up 39% of its $15.8B portfolio in Q2 2014.
- First Manhattan opened 71 new positions and closed 55 in Q2 2014.
- First Manhattan's portfolio value rose 4% quarter-over-quarter to $15.8B.
Based on First Manhattan's 13F filing for Q2 2014, filed 14 Aug 2014.